Inovio Pharmaceuticals
INO
INO
198 hedge funds and large institutions have $330M invested in Inovio Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 55 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
23% less capital invested
Capital invested by funds: $428M → $330M (-$98M)
29% less call options, than puts
Call options by funds: $3.87M | Put options by funds: $5.47M
Holders
198
Holding in Top 10
–
Calls
$3.87M
Puts
$5.47M
Top Buyers
| 1 | +$35.8M | |
| 2 | +$8.39M | |
| 3 | +$4.05M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.93M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.9M |
Top Sellers
| 1 | -$24.6M | |
| 2 | -$3.56M | |
| 3 | -$2.84M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.63M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.95M |